ConforMIS, Inc. is a medical technology company. The Company uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants, which are individually sized and shaped, to fit each patient's anatomy. The Company's iFit technology platform is applicable to various joints. It offers a line of customized knee implants designed to restore the natural shape of a patient's knee. It offers iTotal CR, which is a total knee replacement implant. Its iFit technology platform consists of three elements, including iFit Design, its algorithms and computer software that is used to design customized implants and associated single-use patient-specific instrumentation referred to as iJigs, based on computed tomography scans of the patient and to prepare a surgical plan customized for the patient (iView); iFit Printing, which is a three-dimensional printing technology used to manufacture iJigs, and iFit Just-in-Time manufacturing and delivery capabilities.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Devices & Implants
- Sub-Industry: N/A
- Symbol: NASDAQ:CFMS
- CUSIP: N/A
- Web: www.conformis.com
Capitalization:- Market Cap: $156.03 million
- Outstanding Shares: 44,836,000
Average Prices:- 50 Day Moving Avg: $3.74
- 200 Day Moving Avg: $3.74
- 52 Week Range: $3.46 - $10.93
P/E:- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -3.16
- P/E Growth: 0.23
Sales & Book Value:- Annual Revenue: $79.26 million
- Price / Sales: 1.97
- Book Value: $1.52 per share
- Price / Book: 2.29
Profitability:- EBIDTA: ($54,780,000.00)
- Net Margins: -72.87%
- Return on Equity: -66.61%
- Return on Assets: -49.87%
Debt:- Debt-to-Equity Ratio: 0.43%
- Current Ratio: 6.98%
- Quick Ratio: 6.11%
Misc:- Average Volume: 163,829 shs.
- Beta: 2.3
- Short Ratio: 11.66
Frequently Asked Questions for ConforMIS (NASDAQ:CFMS)
What is ConforMIS's stock symbol?
ConforMIS trades on the NASDAQ under the ticker symbol "CFMS."
How were ConforMIS's earnings last quarter?
ConforMIS, Inc. (NASDAQ:CFMS) announced its quarterly earnings data on Thursday, August, 3rd. The company reported ($0.28) earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($0.36) by $0.08. The business had revenue of $18.50 million for the quarter, compared to analyst estimates of $19.34 million. ConforMIS had a negative net margin of 72.87% and a negative return on equity of 66.61%. The company's revenue was down 4.1% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.34) EPS. View ConforMIS's Earnings History.
When will ConforMIS make its next earnings announcement?
Where is ConforMIS's stock going? Where will ConforMIS's stock price be in 2017?
6 brokers have issued twelve-month price objectives for ConforMIS's stock. Their forecasts range from $5.00 to $11.00. On average, they expect ConforMIS's stock price to reach $7.10 in the next twelve months. View Analyst Ratings for ConforMIS.
Who are some of ConforMIS's key competitors?
Who are ConforMIS's key executives?
ConforMIS's management team includes the folowing people:
- Kenneth Fallon III, Independent Chairman of the Board
- Mark A. Augusti, President, Chief Executive Officer, Director
- Paul S. Weiner, Chief Financial Officer
- Dan Krupp, Senior Vice President - U.S. Sales
- Daniel Steines M.D., Chief Technology Officer
- David Cerveny, Chief Legal Officer and General Counsel
- Philipp Lang M.D., Director
- Bradley R. Langdale, Independent Director
- Colm C. Lanigan, Independent Director
- Richard J. Meelia, Independent Director
When did ConforMIS IPO?
(CFMS) raised $135 million in an initial public offering (IPO) on Wednesday, July 1st 2015. The company issued 9,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Deutsche Bank Securities served as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.
Who owns ConforMIS stock?
ConforMIS's stock is owned by many different of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (3.61%), C Partners Holding Gmbh (3.38%), State Street Corp (1.33%), Northern Trust Corp (1.04%), Platinum Investment Management Ltd. (0.75%) and Columbus Circle Investors (0.51%). Company insiders that own ConforMIS stock include Bradley Langdale, Daniel Steines, David Cerveny, Kenneth P Fallon III, Paul S Weiner, Philipp Lang and Robert Law III. View Institutional Ownership Trends for ConforMIS.
Who sold ConforMIS stock? Who is selling ConforMIS stock?
ConforMIS's stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Frontier Capital Management Co. LLC, Marathon Capital Management, Creative Planning, Goldman Sachs Group Inc., California State Teachers Retirement System and New York State Common Retirement Fund. Company insiders that have sold ConforMIS stock in the last year include Bradley Langdale, Daniel Steines, David Cerveny, Paul S Weiner and Philipp Lang. View Insider Buying and Selling for ConforMIS.
Who bought ConforMIS stock? Who is buying ConforMIS stock?
ConforMIS's stock was purchased by a variety of institutional investors in the last quarter, including ARK Investment Management LLC, Spark Investment Management LLC, PDT Partners LLC, Columbus Circle Investors, Platinum Investment Management Ltd., Northern Trust Corp, Bank of New York Mellon Corp and Trent Capital Management Inc. NC. View Insider Buying and Selling for ConforMIS.
How do I buy ConforMIS stock?
Shares of ConforMIS can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is ConforMIS's stock price today?
One share of ConforMIS stock can currently be purchased for approximately $3.48.
MarketBeat Community Rating for ConforMIS (NASDAQ CFMS)MarketBeat's community ratings are surveys of what our community members think about ConforMIS and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for ConforMIS (NASDAQ:CFMS) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 4 Hold Ratings, 2 Buy Ratings |
| Consensus Rating: | Hold (Score: 2.33) |
| Consensus Price Target: | $7.10 (104.02% upside) |
Analysts' Ratings History for ConforMIS (NASDAQ:CFMS)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 8/4/2017 | Canaccord Genuity | Lower Price Target | Hold | $8.00 -> $6.00 | Low |  |
| 8/4/2017 | Oppenheimer Holdings, Inc. | Set Price Target | Buy | $6.00 | High | |
| 8/4/2017 | Deutsche Bank AG | Reiterated Rating | Buy -> Hold | $6.00 -> $5.00 | High | |
| 7/16/2017 | BTIG Research | Reiterated Rating | Hold | | Low | |
| 5/16/2017 | B. Riley | Reiterated Rating | Buy | $7.50 | Low | |
| 11/4/2016 | J P Morgan Chase & Co | Reiterated Rating | Hold | $11.00 | N/A | |
| 9/19/2016 | SunTrust Banks, Inc. | Initiated Coverage | Buy | $14.00 | N/A | |
| 5/13/2016 | Wells Fargo & Company | Downgrade | Outperform -> Market Perform | | N/A | |
| 12/1/2015 | Sterne Agee CRT | Initiated Coverage | Buy | $26.00 | N/A | |
(Data available from 9/20/2015 forward)
Earnings History for ConforMIS (NASDAQ:CFMS)Earnings History by Quarter for ConforMIS (NASDAQ CFMS)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 11/1/2017 | | ($0.32) | | | | | N/A | |
| 8/3/2017 | Q2 2017 | ($0.36) | ($0.28) | $19.34 million | $18.50 million | View | Listen | |
| 5/10/2017 | Q1 2017 | ($0.36) | ($0.40) | $18.48 million | $20.50 million | View | N/A | |
| 2/15/2017 | Q416 | ($0.30) | ($0.37) | $21.37 million | $21.70 million | View | Listen | |
| 11/3/2016 | Q316 | ($0.36) | ($0.31) | $18.27 million | $18.60 million | View | Listen | |
| 8/8/2016 | Q216 | ($0.35) | ($0.34) | $18.02 million | $19.30 million | View | Listen | |
| 5/12/2016 | Q116 | ($0.38) | ($0.37) | $19.23 million | $20.30 million | View | Listen | |
| 2/11/2016 | Q415 | ($0.41) | ($0.37) | $17.23 million | $19.10 million | View | Listen | |
| 11/2/2015 | Q3 | ($0.38) | ($0.45) | $13.51 million | $13.90 million | View | N/A | |
| 8/11/2015 | Q215 | ($1.31) | ($2.51) | $11.20 million | $19.20 million | View | Listen | |
(Data available from 1/1/2011 forward)
Earnings Estimates for ConforMIS (NASDAQ:CFMS)2017 EPS Consensus Estimate: ($1.41)
2018 EPS Consensus Estimate: ($1.21)
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 3 | ($0.38) | ($0.36) | ($0.37) |
| Q2 2017 | 3 | ($0.39) | ($0.35) | ($0.37) |
| Q3 2017 | 3 | ($0.37) | ($0.29) | ($0.34) |
| Q4 2017 | 3 | ($0.35) | ($0.31) | ($0.33) |
| Q1 2018 | 2 | ($0.34) | ($0.29) | ($0.32) |
| Q2 2018 | 2 | ($0.34) | ($0.28) | ($0.31) |
| Q3 2018 | 2 | ($0.34) | ($0.23) | ($0.29) |
| Q4 2018 | 2 | ($0.34) | ($0.26) | ($0.30) |
(Data provided by Zacks Investment Research)
Dividend History for ConforMIS (NASDAQ:CFMS)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for ConforMIS (NASDAQ:CFMS)Insider Ownership Percentage: 9.55%
Institutional Ownership Percentage: 33.60%
Insider Trades by Quarter for ConforMIS (NASDAQ:CFMS)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 6/20/2017 | Bradley Langdale | Director | Sell | 6,722 | $4.30 | $28,904.60 | |
| 4/26/2017 | Daniel Steines | Insider | Sell | 5,000 | $5.54 | $27,700.00 | |
| 4/5/2017 | Daniel Steines | Insider | Sell | 5,000 | $5.00 | $25,000.00 | |
| 2/15/2017 | Philipp Lang | Director | Sell | 137,968 | $8.60 | $1,186,524.80 | |
| 2/3/2017 | David Cerveny | Insider | Sell | 3,569 | $8.59 | $30,657.71 | |
| 2/3/2017 | Paul S Weiner | CFO | Sell | 2,676 | $8.42 | $22,531.92 | |
| 2/3/2017 | Philipp Lang | Director | Sell | 108,705 | $8.60 | $934,863.00 | |
| 1/25/2017 | Philipp Lang | Director | Sell | 108,985 | $8.60 | $937,271.00 | |
| 1/23/2017 | Philipp Lang | Director | Sell | 9,681 | $8.60 | $83,256.60 | |
| 1/13/2017 | Philipp Lang | Director | Sell | 37,275 | $8.60 | $320,565.00 | |
| 1/11/2017 | Philipp Lang | Director | Sell | 2,800 | $8.62 | $24,136.00 | |
| 1/10/2017 | Philipp Lang | Director | Sell | 83,909 | $8.64 | $724,973.76 | |
| 1/9/2017 | Philipp Lang | Director | Sell | 6,200 | $8.65 | $53,630.00 | |
| 1/5/2017 | Philipp Lang | Director | Sell | 400 | $8.60 | $3,440.00 | |
| 1/3/2017 | Philipp Lang | Director | Sell | 74,876 | $8.00 | $599,008.00 | |
| 12/30/2016 | Philipp Lang | Director | Sell | 168,734 | $8.25 | $1,392,055.50 | |
| 12/28/2016 | Philipp Lang | Director | Sell | 58,547 | $8.26 | $483,598.22 | |
| 12/27/2016 | Philipp Lang | Director | Sell | 42,086 | $8.57 | $360,677.02 | |
| 12/23/2016 | Philipp Lang | Director | Sell | 30,647 | $8.62 | $264,177.14 | |
| 10/17/2016 | Daniel Steines | Insider | Sell | 889 | $8.64 | $7,680.96 | |
| 10/17/2016 | Paul S Weiner | CFO | Sell | 884 | $8.60 | $7,602.40 | |
| 10/12/2016 | Daniel Steines | Insider | Sell | 10,000 | $9.66 | $96,600.00 | |
| 10/5/2016 | Philipp Lang | CEO | Sell | 53,860 | $10.19 | $548,833.40 | |
| 10/4/2016 | Philipp Lang | CEO | Sell | 400 | $10.00 | $4,000.00 | |
| 10/3/2016 | Daniel Steines | CTO | Sell | 10,000 | $10.03 | $100,300.00 | |
| 10/3/2016 | Philipp Lang | CEO | Sell | 10,410 | $10.03 | $104,412.30 | |
| 9/16/2016 | Daniel Steines | Insider | Sell | 30,000 | $9.09 | $272,700.00 | |
| 8/17/2016 | Kenneth P Fallon III | Director | Sell | 4,000 | $8.44 | $33,760.00 | |
| 5/17/2016 | Robert Law III | SVP | Buy | 1,600 | $6.20 | $9,920.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for ConforMIS (NASDAQ:CFMS)
Latest Headlines for ConforMIS (NASDAQ:CFMS)
| Source: |
|
| Date | Headline |
|---|
 | ETFs with exposure to ConforMIS, Inc. : September 19, 2017
finance.yahoo.com - September 19 at 10:13 PM |
| ConforMIS, Inc. :CFMS-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017
finance.yahoo.com - September 18 at 3:38 PM |
 | ConforMIS, Inc. (CFMS) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - September 16 at 8:34 AM |
| $17.69 Million in Sales Expected for ConforMIS, Inc. (CFMS) This Quarter
www.americanbankingnews.com - September 11 at 10:50 AM |
| Head to Head Review: ConforMIS (CFMS) versus Stryker Corporation (SYK)
www.americanbankingnews.com - September 10 at 6:06 AM |
| Comparing Stryker Corporation (SYK) and ConforMIS (CFMS)
www.americanbankingnews.com - September 4 at 12:24 AM |
| ConforMIS, Inc. (CFMS) Upgraded at ValuEngine
www.americanbankingnews.com - September 3 at 7:08 PM |
 | Digital Impulse Ranks No. 3,830 on the 2017 Inc. 5000 with Three-Year Sales Growth of 76%
www.bizjournals.com - August 23 at 5:25 PM |
| ConforMIS, Inc. (CFMS) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - August 22 at 8:34 AM |
| Zacks: Analysts Expect ConforMIS, Inc. (CFMS) Will Post Earnings of -$0.31 Per Share
www.americanbankingnews.com - August 21 at 6:14 PM |
| Financial Contrast: Obalon Therptcs (OBLN) vs. ConforMIS (CFMS)
www.americanbankingnews.com - August 18 at 6:22 AM |
| Head to Head Comparison: Endologix (ELGX) & ConforMIS (CFMS)
www.americanbankingnews.com - August 13 at 12:40 PM |
 | ConforMIS Inc (CFMS) Reports Acquisition of Machine & Polishing Assets from Broad Peak Manufacturing for $6.5M
www.streetinsider.com - August 10 at 6:19 PM |
| Brokers Set Expectations for ConforMIS, Inc.'s Q3 2017 Earnings (NASDAQ:CFMS)
www.americanbankingnews.com - August 10 at 12:04 PM |
| ConforMIS Inc (CFMS) Reports Acquisition of Machine & Polishing ... - StreetInsider.com
www.streetinsider.com - August 9 at 5:18 PM |
| ConforMIS Acquires Machining and Polishing Assets from Broad Peak Manufacturing
finance.yahoo.com - August 9 at 5:18 PM |
| Uroplasty (UPI) & ConforMIS (CFMS) Critical Review
www.americanbankingnews.com - August 9 at 12:24 PM |
| ConforMIS, Inc. (NASDAQ:CFMS) Rating Reiterated by Deutsche Bank AG
www.americanbankingnews.com - August 6 at 9:06 PM |
| Oppenheimer Holdings, Inc. Reiterates $6.00 Price Target for ConforMIS, Inc. (NASDAQ:CFMS)
www.americanbankingnews.com - August 6 at 7:08 PM |
| ConforMIS, Inc. (NASDAQ:CFMS) Price Target Lowered to $6.00 at Canaccord Genuity
www.americanbankingnews.com - August 6 at 3:18 PM |
| ConforMIS (CFMS) vs. Second Sight Medical Products (EYES) Head to Head Review
www.americanbankingnews.com - August 6 at 8:06 AM |
| ConforMIS, Inc. (NASDAQ:CFMS) Expected to Announce Quarterly Sales of $19.76 Million
www.americanbankingnews.com - August 5 at 7:09 AM |
| Pre-Open Movers 08/04: (YELP) (GPRO) (ANET) Higher; (EFII) (AAOI) (PI) Lower (more...)
www.streetinsider.com - August 4 at 10:24 PM |
| ConforMIS, Inc. (CFMS) Announces Quarterly Earnings Results, Beats Estimates By $0.08 EPS
www.americanbankingnews.com - August 4 at 7:30 PM |
| After-Hours Stock Movers 08/03: (YELP) (WTW) (ANET) Higher; (AAOI) (PI) (SYNA) Lower (more...)
www.streetinsider.com - August 4 at 5:23 PM |
| Edited Transcript of CFMS earnings conference call or presentation 3-Aug-17 8:30pm GMT
finance.yahoo.com - August 4 at 4:45 AM |
| ConforMIS reports 2Q loss
finance.yahoo.com - August 3 at 11:40 PM |
| ConforMIS Reports Second Quarter 2017 Financial Results and Updates Fiscal Year 2017 Guidance
finance.yahoo.com - August 3 at 6:37 PM |
| ETFs with exposure to ConforMIS, Inc. : August 1, 2017
finance.yahoo.com - August 1 at 5:52 PM |
 | Will ConforMIS (CFMS) Continue to Surge Higher? - Nasdaq
www.nasdaq.com - July 28 at 6:44 PM |
| Will ConforMIS (CFMS) Continue to Surge Higher?
finance.yahoo.com - July 28 at 6:44 PM |
| ConforMIS, Inc. (NASDAQ:CFMS) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - July 28 at 8:28 AM |
| Notable Wednesday Option Activity: NOW, CFMS, LRCX - Nasdaq
www.nasdaq.com - July 26 at 5:41 PM |
| ConforMIS (CFMS) Worth a Look: Stock Jumps 13.4% in Session
finance.yahoo.com - July 26 at 5:40 PM |
 | ConforMIS to Host Second Quarter 2017 Financial Results Conference Call and Webcast on August 3, 2017 - GlobeNewswire (press release)
globenewswire.com - July 20 at 4:21 AM |
| ConforMIS to Host Second Quarter 2017 Financial Results Conference Call and Webcast on August 3, 2017
finance.yahoo.com - July 19 at 6:17 PM |
| Comparing Uroplasty (UPI) & ConforMIS (NASDAQ:CFMS)
www.americanbankingnews.com - July 19 at 9:34 AM |
| St Jude Medical (STJ) versus ConforMIS (CFMS) Head-To-Head Survey
www.americanbankingnews.com - July 19 at 8:51 AM |
| BTIG Research Reiterates "Hold" Rating for ConforMIS, Inc. (CFMS)
www.americanbankingnews.com - July 18 at 12:56 AM |
| Financial Comparison: ConforMIS (CFMS) and St Jude Medical (STJ)
www.americanbankingnews.com - July 17 at 2:31 PM |
| $19.40 Million in Sales Expected for ConforMIS, Inc. (NASDAQ:CFMS) This Quarter
www.americanbankingnews.com - July 14 at 4:24 PM |
| ConforMIS, Inc. (CFMS) Rating Increased to Buy at Zacks Investment Research
www.americanbankingnews.com - July 12 at 7:10 PM |
| ConforMIS Names Dan Krupp Senior Vice President US Sales - GlobeNewswire (press release)
globenewswire.com - July 12 at 5:42 PM |
| Brokerages Expect ConforMIS, Inc. (NASDAQ:CFMS) Will Post Earnings of -$0.36 Per Share
www.americanbankingnews.com - July 12 at 8:30 AM |
| Zacks Investment Research Lowers ConforMIS, Inc. (CFMS) to Sell
www.americanbankingnews.com - July 11 at 10:52 PM |
| ETFs with exposure to ConforMIS, Inc. : July 11, 2017
finance.yahoo.com - July 11 at 6:08 PM |
| ConforMIS Names Dan Krupp Senior Vice President U.S. Sales
finance.yahoo.com - July 11 at 6:08 PM |
| ConforMIS, Inc. (CFMS) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - July 3 at 10:59 AM |
| ETFs with exposure to ConforMIS, Inc. : June 26, 2017
finance.yahoo.com - June 26 at 4:56 PM |
| RTI Surgical (RTIX) vs. ConforMIS (CFMS) Head to Head Contrast
www.americanbankingnews.com - June 25 at 12:17 PM |
ConforMIS (CFMS) Chart for Wednesday, September, 20, 2017
